Exact Mass: 358.2409

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

NCIOpen2_007672

16-Butyl-3-methoxy-estra-1,3,5(10)-triene-16beta,17beta-diol

11beta-Hydroxy-6alpha,11-dimethylprogesterone

11beta-Hydroxy-6alpha,11-dimethylpregn-4-ene-3,20-dione; 11beta-Hydroxy-6alpha,11-dimethylprogesterone

D-Homotestosterone propionate

17abeta-Hydroxy-D-homoandrost-4-en-3-one propionate; D-Homotestosterone propionate

6305-06-2

17beta-Hydroxy-7alpha-methylandrost-4-en-3-one propionate

Kinetensin 1-3

(2S)-2-{[(2S)-2-{[(2S,3S)-2-amino-1-hydroxy-3-methylpentylidene]amino}-1-hydroxypropylidene]amino}-5-carbamimidamidopentanoate

Kinetensin 1-3 is a fraction of kinetensin with only the Ile-Ala-Arg peptide chain. Kinetensin is a nonapeptide, originally isolated from pepsin-treated plasma that shares some sequence homology with the C-terminal end of neurotensin, serum albumin, and angiotensin. It is a potent histamine releaser in rodents and may serve as an inflammatory mediator. Kinetensin 1-3 is a fraction of Kinetensin with only Ile-Ala-Arg peptide chain.

24,25,26,27-Tetranor-23-oxo-hydroxyvitamin D3

(3S)-3-[(1S,3aR,4E,7aS)-4-{2-[(1E,3R,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-hexahydro-1H-inden-1-yl]butanal

This compound belongs to the family of Steroids and Steroid Derivatives. These are compounds based on the cyclopenta[a]phenanthrene carbon skeleton, partially or completely hydrogenated; there are usually methyl groups at C-10 and C-13, and often anÂ alkyl groupÂ at C-17. By extension, one or more bond scissions, ring expansions and/or ring contractions of the skeleton may have occurred.

Pracinostat

N-Hydroxy3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-1,3-benzodiazol-5-yl}prop-2-enimidate

Testosterone isobutyrate

(10,13-Dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) 2-methylpropanoate

(3alpha,14beta)-14,16-epoxy-3,18-[(1-methylethane-1,1,diyl)dioxy]-ent-abieta-7,15(17)-diene-14,16-diol

Allopregn-16-enolone acetate

Ac-(3beta,5alpha)-3-Hydroxypregn-14-ene-20-one

Asteriscunolide B

MTDQ

C25H30N2 (358.2409)

dasyscyphin B

phellinic acid

DTXSID30836399

DTXSID00422506

niuhinone C

C19H34O6

7beta-acetoxypregn-20-en-3-one|ceratosteroid B

incisterol A5

manadoperoxide H

C23H34O3

(3beta,5beta,14beta)-14,21-epoxy-24-norcholan-20,22-diene-3,5-diol

19,20-dihydromiliusolide

2-alpha-acetyloxy-5-alpha-pregn-17(20)-(cis)-en-16-one

FT-0674878

chamaetexane C acetonide

Ile-Arg-Ala

11alpha-acetoxy-5alpha-pregn-20-en-3-one

Ala Arg Ile

FT-0617218

Leu Arg Gly

3-[2-butyl-1-[2-(diethylamino)ethyl]-5-benzimidazolyl]-N-hydroxy-2-propenamide

Arg Ile Ala

Leu Gly Arg

Arg Leu Gly

Gly Leu Arg

alanylisoleucylarginine

Gly Arg Leu

Arg Gly Leu

Arg Ala Ile

methoxydihydrosorgoleone

MLS000069411-01!PREGNENOLONE ACETATE

Leu Ala Arg

Leu Arg Ala

Ala Ile Arg

Ile Arg Ala

Arg Ala Leu

Ala Arg Leu

Ile Ala Arg

Arg Leu Ala

Ala Leu Arg

tetranor-23-oxo-1alpha(OH)D3

(1S,3R,5Z,7E)-1,3-dihydroxy-24-nor-9,10-secochola-5,7,10(19)-trien-23-al

4(5)-EpDPE methyl ester

4,5-epoxy-7Z,10Z,13Z,16Z,19Z-docosapentaenoic acid, methyl ester

SB 939

Pracinostat (SB939)

ascr#21

12R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-tridecanoic acid

An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,12R)-12-hydroxytridec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

oscr#21

13-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-tridecenoic acid

An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-13-hydroxytridec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

GLYCOLIC ACID ETHOXYLATE 4-NONYLPHENYL ETHER

GLYCEROL DIACETATE LAURATE

(3β,5α)-20-Oxopregn-16-en-3-yl acetate

Testosterone 17-Isobutyrate

(1S,2S,3S,4R)-3-[(1S)-1-Amino-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-cyclopentanecarboxylic acid methyl ester

C18H34N2O5 (358.2468)

2,2’-(2,5-Dimethyl-1,4-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)

C20H32B2O4 (358.2487)

Bis[(+)-pinanediolato]diboron

C20H32B2O4 (358.2487)

Bis[(-)pinanediolato]diboron

C20H32B2O4 (358.2487)

5-ethyl-2-methylidenenonanoic acid,methyl propanoate,prop-2-enoic acid

(2E,12R)-12-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tridec-2-enoic acid

16-Butyl-3-methoxy-estra-1,3,5(10)-triene-16beta,17beta-diol

17beta-Hydroxy-7alpha-methylandrost-4-en-3-one propionate

Pracinostat

Pracinostat (SB939)

C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent

(2E)-13-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tridec-2-enoic acid

Leu-Ala-Arg

((2,2-Dimethyl-3-vinyl-2H-chromen-7-yl)oxy)triisopropylsilane

C22H34O2Si (358.2328)

Ala-Arg-Leu

Arg-Ala-Ile

Ala-Leu-Arg

Arg-Ala-Leu

Arg-Leu-Ala

Leu-Arg-Ala

6,7-dimethoxy-N,N-dipropyl-2-(1-pyrrolidinyl)-4-quinazolinamine

Arg-Ile-Ala

Ala-Ile-Arg

Ala-Arg-Ile

Kinetensin 1-3

L-Isoleucyl-L-alanyl-L-arginine

24,25,26,27-Tetranor-23-oxo-hydroxyvitamin D3

(1S)-1-hydroxy-23-oxo-24,25,26,27-tetranorcalciol

7alpha-Methyltestosterone propionate

17beta-Hydroxy-7alpha-methylandrost-4-en-3-one propionate

Hydroxytricosahexaenoic acid

Ile-Ala-Arg

ST 23:3;O3

(1e,3as,3br,5as,7r,9as,9bs,11as)-1-ethylidene-9a,11a-dimethyl-2-oxo-dodecahydro-3h-cyclopenta[a]phenanthren-7-yl acetate

(1r,5r,6r)-4-ethyl-5-hydroxy-1-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-7-oxabicyclo[4.1.0]hept-3-en-2-one

(2s,5r,6r,10r,13s,14r)-13-acetyl-2,5,10,14-tetramethyltetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadec-1(9)-ene-5-carboxylic acid

(1r,3as,3bs,4s,7r,9ar,9bs,11ar)-1-ethenyl-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

3-hydroxypregn-17(20)-en-16-one; (3α,5α,17(20)e)-form,ac

{"Ingredient_id": "HBIN008743","Ingredient_name": "3-hydroxypregn-17(20)-en-16-one; (3\u03b1,5\u03b1,17(20)e)-form,ac","Alias": "NA","Ingredient_formula": "C23H34O3","Ingredient_Smile": "NA","Ingredient_weight": "358.51","OB_score": "NA","CAS_id": "166901-88-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8072","PubChem_id": "NA","DrugBank_id": "NA"}

(1r,4s,7s,9ar,11ar)-1-ethenyl-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

(1r,3as,3bs,4s,7s,9ar,9bs,11ar)-1-ethenyl-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

16-(2h-1,3-benzodioxol-5-yl)hexadec-15-en-2-one

4-ethenyl-8,8,13,13,17-pentamethyl-7,9-dioxatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadec-4-en-3-one

(3e,5e)-6-[(1ar,2r,3s,3as,6s,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-6-hydroxy-1a,6-dimethyl-octahydronaphtho[1,2-b]oxiren-3-yl]-3-methylhexa-3,5-dien-2-one

(1s,2s,5s,9r,13s,14s,19r)-1,14,17,17-tetramethyl-6-methylidene-8,16,18-trioxapentacyclo[11.8.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]henicos-10-ene